Veri-te™
High-purity, > 98% trans-resveratrol backed by proprietary clinical studies
RESHAW clinical study, with Veri-te™
The RESHAW (Resveratrol Supporting Healthy Aging in Women) clinical study followed 125 postmenopausal women during a 24-month crossover comparison. Volunteers were randomized to take two capsules containing 75mg of Veri-te™ resveratrol daily or a matching placebo supplement for 12 months, followed by the alternate treatment for a further 12 months.
Significant benefits were seen for cognitive & cerebrovascular function, longevity, mood & overall well-being, menopausal discomfort, bone health and skin health.
RESHAW is the largest, longest-running study of its kind with resveratrol. We continue to invest in human clinical studies to contribute to the expanding body of evidence that resveratrol supports healthy living.
Veri-te™ was chosen as a finalist for the 2026 NutraIngredients Europe Ingredient-of-the-Year Award for Beauty-From-Within.
While resveratrol has been widely studied for healthy aging related benefits, its direct impact on skin appearance through dietary supplementation had never been demonstrated, until now.
Veri‑te™ is the first resveratrol to be clinically evaluated as a standalone active for beauty-from-within applications.
This breakthrough positions Veri‑te™ as the resveratrol ingredient that delivers real-world, measurable outcomes for beauty-from-within brands seeking clinically substantiated differentiation.